Acute and chronic migraine treatment from standard therapies to new therapeutic options: A review of current knowledge (2019–2025)
Year: 2026
Type: article
Abstract: Research objective: Migraine is a neurological disorder that significantly reduces patients' quality of life, social functioning, and professional productivity. The aim of this review is to present current treatment options for both acute migraine attacks and chronic migraine prevention, with particular focus on advances recorded between 2019 and 2025. Methodology: A narrative review of current knowledge was conducted, encompassing randomized clinical trials, meta-analyses, and clinical guidelines published between 2019 and 2025 concerning pharmacological and non-pharmacological treatment of acute and chronic migraine. Main conclusions: In the treatment of acute migraine attacks, NSAIDs remain the basis of therapy for mild to moderate episodes, while triptans are recommended for moderate to severe attacks. New drug classes — gepants (rimegepant, ubrogepant, zavegepant) and ditans (lasmiditan) — provide effective alternatives. Monoclonal anti-CGRP antibodies (erenumab, fremanezumab, galcanezumab, eptinezumab) and oral CGRP receptor antagonists have been shown to significantly reduce the number of migraine days and improve quality of life. OnabotulinumtoxinA remains an effective preventive treatment for chronic migraine. Application of the study: The findings support clinicians in selecting individualized treatment strategies for migraine patients by providing a comprehensive and up-to-date overview of available pharmacological and neuromodulation options, taking into account disease severity, comorbidities, and cost-availability factors. Originality/Novelty of the study: The review integrates evidence from the most recent clinical trials and meta-analyses (2019–2025), highlighting the paradigm shift in migraine management brought about by targeted CGRP-based therapies and non-invasive neuromodulation methods, enabling more personalized and effective patient care.
Institution: Gdańsk Medical University
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W7162249263
